To investigate the pathophysiological role of m7G methylation modification in the induction of drug resistance in AML cells, we performed GO enrichment and KEGG pathway analyses on different m7G methylation genes in HL60/MX2 and HL60 cells. This evidence concerns the gene MX2 and acute myeloid leukemia.